Gotham Asset Management’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.98M	Buy	312,961 +96,015	+44%	+$746K	0.01%	997
2025 Q4	$1.69M	Sell	216,946 -126,825	-37%	-$917K	0.01%	1096
2025 Q3	$2.61M	Buy	343,771 +141,958	+70%	+$1.18M	0.01%	931
2025 Q2	$1.81M	Buy	201,813 +157,749	+358%	+$1.47M	0.01%	956
2025 Q1	$330K	Buy	+44,064	New	+$355K	﹤0.01%	1337
2024 Q4	–	Sell	-38,893	Closed	-$296K	–	1432
2024 Q3	$296K	Buy	+38,893	New	+$296K	﹤0.01%	1223
2023 Q4	–	Sell	-69,033	Closed	-$489K	–	1336
2023 Q3	$489K	Buy	+69,033	New	+$496K	0.01%	970
2022 Q4	–	Sell	-24,034	Closed	-$303K	–	1211
2022 Q3	$303K	Buy	+24,034	New	+$309K	0.01%	976
2022 Q2	–	Sell	-14,548	Closed	-$237K	–	1120
2022 Q1	$237K	Buy	14,548 +3,240	+29%	+$52K	0.01%	1024
2021 Q4	$157K	Buy	+11,308	New	+$150K	0.01%	1095
2021 Q3	–	Sell	-48,641	Closed	-$769K	–	1025
2021 Q2	$769K	Buy	+48,641	New	+$661K	0.03%	564
2021 Q1	–	Sell	-14,658	Closed	-$109K	–	985
2020 Q4	$109K	Buy	14,658 +694	+5%	+$3.58K	﹤0.01%	966
2020 Q3	$48K	Sell	13,964 -1,176	-8%	-$5.04K	﹤0.01%	999
2020 Q2	$72K	Sell	15,140 -13,228	-47%	-$52.8K	﹤0.01%	1024
2020 Q1	$57K	Buy	+28,368	New	+$78.1K	﹤0.01%	1026
2017 Q2	–	Sell	-126,553	Closed	-$1.06M	–	967
2017 Q1	$1.06M	Buy	+126,553	New	+$880K	0.01%	657
2016 Q1	–	Sell	-19,424	Closed	-$200K	–	968
2015 Q4	$200K	Buy	+19,424	New	+$193K	﹤0.01%	819